Zhongnan Medical Journal Press

Home Results

A total of 5 result was found. Results that relate to Tyrosine kinase inhibitor

Data mining for hypertension associated with VEGFR-TKIs: based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1201-1208.
2588 times 752 times

Xiao-Lan LIAO Jia-Qi GE Hai-Bin ZHU Ting-Ting WU Chun-Xia REN Zi-Cheng YU

Vascular endothelial growth factor receptor-tyrosine kinase inhibitors Hypertension Adverse drug events Pharmacovigilance FAERS database
Details
Rapid progression of colitis caused by lenvatinib combined with tislelizumab for hepatocellular carcinoma treatment: a case study

Published on Chinese Journal of Pharmacoepidemiology 2024,33(3):349-354.
3226 times 1698 times

MA Jinyuan WANG Bei ZHU Quangang WANG Zhengxin TAO Yifeng QIU Xiaoyan

Tyrosine kinase inhibitor Anti-PD-1 Immune-related adverse reactions Immune-related colitis Case report
Details
Risk of vascular endothelial growth factor receptor tyrosine kinase inhibitor induced hepatotoxicity: a network Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(12):1400-1413.
1805 times 163 times

JIN Mi WANG Chenxiang YE Zhongjiang ZHOU Ziye

Vascular endothelial growth factor receptor tyrosine kinase inhibitor Hepatotoxicity Network Meta-analysis Randomized controlled trials
Details
Myocardial infarction induced by penpulimab and anlotinib: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):231-235.
966 times 132 times

WANG Chunhui JIANG Mengfei WU Wei ZHOU Yuhong

Immune checkpoint inhibitor Tyrosine kinase inhibitor Myocardial infarction Adverse drug reaction
Details
Signal mining of adverse drug reaction related to MET-TKIs after marketing based on FAERS database

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):300-310.
508 times 69 times

WANG Meisa HAN Qiushuang GAO Liang JIANG Yuan CHEN Zhe

Mesenchymal-epithelial transition factor tyrosine kinase inhibitors Food and Drug Administration Adverse Event Reporting System Adverse event signal mining Disproportionality analysis Pharmacovigilance
Details